CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CALC CALCIMEDICA

Trading 04-13 14:34:37 EDT

0.6651

+0.0473

+7.66%

High0.6980	Low0.6200	Vol92.30K
Open0.6200	D1 Closing0.6178	Amplitude12.63%
Mkt Cap10.47M	Tradable Cap5.50M	Total Shares15.74M
T/O61.95K	T/O Rate1.12%	Tradable Shares8.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":0.6651,"timestamp":1776105062116,"preClose":0.6178,"halted":0,"volume":92300,"delay":0,"changeRate":0.07656199417287149,"floatShares":8263900,"shares":15743900,"eps":-1.97,"marketStatus":"Trading","change":0.0473,"latestTime":"04-13 14:34:37 EDT","open":0.62,"high":0.698,"low":0.62,"amount":61948.737175,"amplitude":0.126254,"askPrice":0.6699,"askSize":500,"bidPrice":0.6601,"bidSize":964,"shortable":3,"etf":0,"ttmEps":-1.97,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1776110400000},"marketStatusCode":2,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":0.6178,"preHourTrading":{"tag":"盘前","latestPrice":0.628,"preClose":0.6178,"latestTime":"09:29 EDT","volume":1799,"amount":1157.49088406,"timestamp":1776086971515,"change":0.0102,"changeRate":0.01651,"amplitude":0.0955},"postHourTrading":{"tag":"盘后","latestPrice":0.637,"preClose":0.6178,"latestTime":"19:56 EDT","volume":1064,"amount":672.8898,"timestamp":1775865406864,"change":0.0192,"changeRate":0.031078,"amplitude":0.031078},"volumeRatio":0.316833,"impliedVol":1.8027,"impliedVolPercentile":0.7903},"requestUrl":"/m/hq/s/CALC/tweets","defaultTab":"tweets","newsList":[{"id":"2620207260","title":"CalciMedica Receives Nasdaq Deficiency Notices on Listing Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2620207260","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620207260?lang=en_us&edition=fundamental","pubTime":"2026-03-19 05:04","pubTimestamp":1773867899,"startTime":"0","endTime":"0","summary":"CalciMedica ( ($CALC) ) has shared an update. On March 13, 2026, CalciMedica, Inc. received notice from Nasdaq that it was not in compliance with L...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/calcimedica-receives-nasdaq-deficiency-notices-on-listing-standards?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/calcimedica-receives-nasdaq-deficiency-notices-on-listing-standards?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262045","title":"CalciMedica flags Nasdaq noncompliance as market value falls below USD 35 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262045","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262045?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:33","pubTimestamp":1773865990,"startTime":"0","endTime":"0","summary":"CalciMedica received a Nasdaq notice that it is not in compliance with Listing Rule 5550 after its market value of listed securities stayed below USD 35 million for 30 consecutive business days. The company has until September 9, 2026 to regain compliance, including by maintaining a market value of listed securities of at least USD 35 million for at least 10 consecutive business days. CalciMedica also received a Nasdaq notice that it is not in compliance with Listing Rule 5550 because its minimum bid price was below USD 1 per share for 30 consecutive business days. The company has until September 14, 2026 to regain compliance by maintaining a minimum bid price of at least USD 1 per share for at least 10 consecutive business days.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLJrM4m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617751632","title":"U.S. RESEARCH ROUNDUP-Broadcom, CNX Resources, Veeva Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2617751632","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617751632?lang=en_us&edition=fundamental","pubTime":"2026-03-05 15:16","pubTimestamp":1772695016,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Broadcom, CNX Resources, Veeva SystemsMarch 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Broa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL8N3ZT0FO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBWI","BLLN","CRWU","CALC","AAPB","AVGG","AVGW","CHRD","AEO","BBY","BRBR","CCL","TGT","AAPY","MACW.SI","ANAB","ANF","CRWV","CHWY","VEEV","CCRN","AMT","AR","AAPL","AZO","ASPN","AAPX","CBRL","CLYM","BGS","AVGO","CON","RCEL","APP","APA","LEU","CCI","XYZ","CRC","CSR","APPX","CRWD","CNX","COHR","AVGX","COP","CTRA","CCOI","CRWG","AFRM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2616372797","title":"BRIEF-Calcimedica Inc Files For Mixed Shelf Of Up To $125 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616372797","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616372797?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:02","pubTimestamp":1772575356,"startTime":"0","endTime":"0","summary":"BRIEF-Calcimedica Inc Files For Mixed Shelf Of Up To $125 Million - SEC FilingMarch 3 (Reuters) - CalciMedica Inc CALC.O:CALCIMEDICA INC FILES FOR MIXED SHELF OF UP TO $125 MILLION - SEC FILINGFurther company coverage: CALC.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR0U2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616377434","title":"CalciMedica files $125M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2616377434","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616377434?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:00","pubTimestamp":1772575259,"startTime":"0","endTime":"0","summary":"16:55 EST CalciMedica (CALC) files $125M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-files-125m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-files-125m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616372947","title":"CalciMedica Inc Files for Mixed Shelf of up to $125 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616372947","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616372947?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:55","pubTimestamp":1772574927,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR0U2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616378136","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616378136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616378136?lang=en_us&edition=fundamental","pubTime":"2026-03-04 01:40","pubTimestamp":1772559608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CalciMedica (CALC – Research Report) and Talphera (TLPH – Researc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-calcimedica-calc-and-talphera-tlph-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-calcimedica-calc-and-talphera-tlph-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLPH","BK4588","LU0128526141.USD","BK4007","HCSG","LU0029874061.USD","BK4585","BK4581","XLV","LABU","XBI","CALC","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616347466","title":"CalciMedica Q4 EPS $(0.69) Misses $(0.42) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2616347466","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616347466?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:36","pubTimestamp":1772541376,"startTime":"0","endTime":"0","summary":"CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.42) by 65.47 percent. This is a 102.94 percent decrease over losses of $(0.34) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/50995881/calcimedica-q4-eps-0-69-misses-0-42-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616347575","title":"CalciMedica FY EPS $(1.97) Misses $(1.62) Estimate, Cash Balance Of $13M Provides Cash runway Into Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2616347575","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616347575?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:24","pubTimestamp":1772540640,"startTime":"0","endTime":"0","summary":"CalciMedica FY EPS $(1.97) Misses $(1.62) Estimate, Cash Balance Of $13M Provides Cash runway Into Q4 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/50995618/calcimedica-fy-eps-1-97-misses-1-62-estimate-cash-balance-of-13m-provides-cash-runway-into-q4-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616342894","title":"CalciMedica posts FY 2025 net loss of USD 29.6 million, up 2.2x","url":"https://stock-news.laohu8.com/highlight/detail?id=2616342894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616342894?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:01","pubTimestamp":1772539276,"startTime":"0","endTime":"0","summary":"CalciMedica reported a FY 2025 net loss of USD 29.6 million and a loss per share of USD 1.97. R&D expenses were USD 15.2 million and G&A expenses were USD 7.9 million. Cash, cash equivalents and short-term investments totaled USD 13.0 million at December 31, 2025, which CalciMedica said is expected to fund its current operating plan into Q4 2026. On the pipeline, CalciMedica said internal and external reviews of unblinded Phase 2 KOURAGE data in acute kidney injury with acute hypoxemic respiratory failure found no evidence of drug-related toxicity with Auxora, after the trial was discontinued in January 2026 following an IDMC recommendation tied to a mortality imbalance. The company plans to discuss the KOURAGE data and potential future AKI development with the FDA in Q2 2026. In acute pancreatitis, CalciMedica said it expects to finalize the design of its pivotal Auxora program in H1 2026 following FDA engagement, and highlighted publication of Phase 2b CARPO results in eClinicalMedic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL4dYZbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616447233","title":"CalciMedica Reports 2025 Financial Results and Provides Clinical Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2616447233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616447233?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:00","pubTimestamp":1772539204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUABGRRWN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607349270","title":"This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2607349270","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607349270?lang=en_us&edition=fundamental","pubTime":"2026-01-30 00:28","pubTimestamp":1769704080,"startTime":"0","endTime":"0","summary":"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.\nConsidering buying CALC stock? Here’s what analysts think: \nPhoto via Shutterstock","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/29/Analyst-Woman-Working-With-Information-D_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/29/Analyst-Woman-Working-With-Information-D_0.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/downgrades/26/01/50237685/this-calcimedica-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-thursday","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/downgrades/26/01/50237685/this-calcimedica-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-thursday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4112","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607847600","title":"HC Wainwright Downgrades CalciMedica to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2607847600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607847600?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:26","pubTimestamp":1769689587,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) has an average rating of overweight and mean price target of $16.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607089704","title":"CalciMedica Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2607089704","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607089704?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:52","pubTimestamp":1769687520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 29, 2026 06:52 ET (11:52 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607865370","title":"CalciMedica downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2607865370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607865370?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:11","pubTimestamp":1769685078,"startTime":"0","endTime":"0","summary":"H.C. Wainwright downgraded CalciMedica (CALC) to Neutral from Buy without a price target The immediate discontinuation for the Phase 2 KOURAGE clin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607726109","title":"CalciMedica Inc - Discontinues Phase 2 Kourage Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607726109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607726109?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:30","pubTimestamp":1769639432,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1EW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607272643","title":"CalciMedica: Updates Financial Guidance After Trial Discontinuation, NOW Expects Funds to Last Into Q4 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607272643","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607272643?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:30","pubTimestamp":1769639432,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT1EW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607726157","title":"CalciMedica Extends Cash Runway Into Fourth Quarter of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2607726157","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607726157?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:29","pubTimestamp":1769639376,"startTime":"0","endTime":"0","summary":"CalciMedica Inc. has updated its financial guidance following the discontinuation of its Phase 2 KOURAGE clinical trial. The company now anticipates that its existing cash, cash equivalents, and short-term investments will be sufficient to fund its current operating plan into the fourth quarter of 2026. This marks an improvement from its previous expectation, which projected funding only into the second half of 2026, reflecting a reduction in planned operating expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL2Nxtt1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607774346","title":"Calcimedica Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2607774346","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607774346?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:40","pubTimestamp":1769614822,"startTime":"0","endTime":"0","summary":"10:35 EST Calcimedica (CALC) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-inc-trading-resumes-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606748845","title":"CalciMedica Shares Hit 52-Week Low After Ending Auxora Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2606748845","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606748845?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:09","pubTimestamp":1769612940,"startTime":"0","endTime":"0","summary":"CalciMedica shares were 82% lower, at 91 cents, after the company said it was discontinuing its Phase 2 clinical trial evaluating Auxora in patients with Stage 2 or Stage 3 acute kidney injury with associated acute hypoxemic respiratory failure.The stock hit its 52-week low of 82 cents earlier in the session, and is down 66% in the past 12 months.The clinical-stage biopharmaceutical company said the decision follows a recommendation from the trial's independent data monitoring committee.During a prescheduled interim data review, the committee identified a safety concern that, in its view, warrants reevaluation of the study design, particularly with respect to patient enrollment criteria.The company said that there were no deaths in the trial that were assessed by investigators or CalciMedica as being related to study drug, with either Auxora or a placebo. No serious adverse events met the criteria for expedited reporting to the Food and Drug Administration.Based on the committee's reco","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://calcimedica.com;ir.calcimedica.com","stockEarnings":[{"period":"1week","weight":0.0561},{"period":"1month","weight":-0.1071},{"period":"3month","weight":-0.8944},{"period":"6month","weight":-0.8048},{"period":"1year","weight":-0.5826},{"period":"ytd","weight":-0.9063}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.093409},{"month":2,"riseRate":0,"avgChangeRate":-0.254297},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.215568},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.026426},{"month":5,"riseRate":0.4,"avgChangeRate":-0.021756},{"month":6,"riseRate":0.4,"avgChangeRate":0.018521},{"month":7,"riseRate":0.4,"avgChangeRate":0.171537},{"month":8,"riseRate":0.4,"avgChangeRate":-0.074652},{"month":9,"riseRate":0.6,"avgChangeRate":-0.007161},{"month":10,"riseRate":0.4,"avgChangeRate":-0.031218},{"month":11,"riseRate":0.333333,"avgChangeRate":0.111978},{"month":12,"riseRate":0.666667,"avgChangeRate":0.040206}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}